Showing results (81-90 of 183) with videos related to
Sort By:
Pageof 19
Breast Cancer Research and Treatment|August 21, 2019
Pathologic complete response and outcomes by intrinsic subtypes in NSABP B-41, a randomized neoadjuvant trial of chemotherapy with trastuzumab, lapatinib, or the combinationSandra M Swain, Gong Tang, Peter C Lucas, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 27, 2004
A phase II trial of neoadjuvant docetaxel and capecitabine for locally advanced breast cancerPeter F Lebowitz, Jennifer Eng-Wong, Sandra M Swain, et al.Investigational New Drugs|August 26, 2006
Phase II trial of ixabepilone, an epothilone B analog, given daily for three days every three weeks, in metastatic breast cancerNeelima Denduluri, James J Lee, Janice Walshe, et al.Pharmacogenomics|September 24, 2020
Assessment of primary care practitioners' attitudes and interest in pharmacogenomic testingD Max Smith, Tarlan Namvar, Ryan P Brown, et al.Proceedings of the National Academy of Sciences of the United States of America|September 23, 2021
Functional succinate dehydrogenase deficiency is a common adverse feature of clear cell renal cancerRitesh K Aggarwal, Rebecca A Luchtel, Venkata Machha, et al.Breast Cancer Research and Treatment|August 11, 2020
Actionable co-alterations in breast tumors with pathogenic mutations in the homologous recombination DNA damage repair pathwayArielle L Heeke, Joanne Xiu, Andrew Elliott, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 4, 2007
Phase II trial of ixabepilone, an epothilone B analog, in patients with metastatic breast cancer previously untreated with taxanesNeelima Denduluri, Jennifer A Low, James J Lee, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 7, 2004
Phase I trial of the cyclin-dependent kinase inhibitor flavopiridol in combination with docetaxel in patients with metastatic breast cancerAntoinette R Tan, Xiaowei Yang, Arlene Berman, et al.Clinical and Translational Science|January 22, 2020
Pharmacogenetics in Practice: Estimating the Clinical Actionability of Pharmacogenetic Testing in Perioperative and Ambulatory SettingsD Max Smith, Beth N Peshkin, T Blaise Springfield, et al.Cancers|November 9, 2024
Correction: Nelson et al. UGT1A1 Guided Cancer Therapy: Review of the Evidence and Considerations for Clinical Implementation. Cancers 2021, 13, 1566Ryan S Nelson, Nathan D Seligson, Sal Bottiglieri, et al.Pageof 19